Chronic obstructive pulmonary disease diagnosis: The simpler the better? Not always

European Journal of Internal Medicine

Volumn 24, Issue 3, 2013, Pages 199-202

  Di Marco, Fabiano ^a   Tantucci, Claudio ^b   Pellegrino, Giulia ^a   Centanni, Stefano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

COPD; Diagnosis; Spirometry

Indexed keywords

AIRWAY RESISTANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; EARLY DIAGNOSIS; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERTENSION; LUNG COMPLIANCE; LUNG DIFFUSION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG VOLUME; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; RESIDUAL VOLUME; REVIEW; RISK FACTOR; SLOW VITAL CAPACITY; SMOKING; SPIROMETRY; THORAX RADIOGRAPHY;

EID: 84875226171     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.01.008     Document Type: Note

References (38)

1. World Health Report Geneva World Health Organization Available from URL: http://who.int/whr/2000/en/statistics.htm 2000
2. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, and L. Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
3. J.C. Hogg, P.T. Macklem, and W.M. Thurlbeck Site and nature of airway obstruction in chronic obstructive lung disease N Engl J Med 278 1968 1355 1360
4. M.S. Dunnill, G.R. Massarella, and J.A. Anderson A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema Thorax 24 1969 176 179
5. L. Reid Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis Thorax 15 1960 132 141
6. J.R. Spurzem, A.B. Thompson, D.M. Daughton, M. Mueller, J. Linder, and S.I. Rennard Chronic inflammation is associated with an increased proportion of goblet cells recovered by bronchial lavage Chest 100 1991 389 393
7. W.D. Kim, D.H. Eidelman, J.L. Izquierdo, H. Ghezzo, M.P. Saetta, and M.G. Cosio Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities Am Rev Respir Dis 144 1991 1385 1390
8. M. Pistolesi, G. Camiciottoli, M. Paoletti, C. Marmai, F. Lavorini, and E. Meoni Identification of a predominant COPD phenotype in clinical practice Respir Med 102 2008 367 376
9. Lung Function Tests J.M.B. Hughes, and N.B. Pride Physiological principles and clinical applications 1999 W.B. Saunders London
10. M. Saetta, H. Ghezzo, W.D. Kim, M. King, G.E. Angus, and N.S. Wang Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment Am Rev Respir Dis 132 1985 894 900
11. D.M. Mannino Should we be using statistics to define disease? Thorax 63 2008 1031 1032
12. A. Johannessen, S. Lehmann, E.R. Omenaas, G.E. Eide, P.S. Bakke, and A. Gulsvik Post-bronchodilator spirometry reference values in adults and implications for disease management Am J Respir Crit Care Med 173 2006 1316 1325
13. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, and D.M. Mannino International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 2007 741 750
14. C. Tantucci, and V. Grassi Flow limitation: an overview Monaldi Arch Chest Dis 54 1999 353 357
15. D.V. Bates Respiratory function in disease 3rd ed. 1989 [Philadelphia WS]
16. N.B. Pride, MPLmidIMP, and J. Mead Handbook of Physiology. The Respiratory System. Mechanics of Breathing. Section 3, Vol. III, part 2 1986 American Physiological society Bethesda 659 692
17. J. Roca, F. Burgos, J. Sunyer, M. Saez, S. Chinn, and J.M. Anto References values for forced spirometry. Group of the European Community Respiratory Health Survey Eur Respir J 11 1998 1354 1362
18. R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, and R. Casaburi Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
19. Evaluation of impairment/disability secondary to respiratory disorders. American Thoracic Society Am Rev Respir Dis 133 1986 1205 1209
20. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society Am Rev Respir Dis 144 1991 1202 1218
21. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society Am J Respir Crit Care Med 152 1995 S77 S121
22. P.H. Quanjer, P.L. Enright, M.R. Miller, J. Stocks, G. Ruppel, and M.P. Swanney Open letter: the need to change the method for defining mild airway obstruction Prim Care Respir J 19 2010 288 291
23. P.H. Quanjer, P.L. Enright, M.R. Miller, J. Stocks, G. Ruppel, and M.P. Swanney The need to change the method for defining mild airway obstruction Eur Respir J 37 2011 720 722
24. A.N. Aggarwal, D. Gupta, D. Behera, and S.K. Jindal Comparison of fixed percentage method and lower confidence limits for defining limits of normality for interpretation of spirometry Respir Care 51 2006 737 743
25. I. Cerveri, A.G. Corsico, S. Accordini, R. Niniano, E. Ansaldo, and J.M. Anto Underestimation of airflow obstruction among young adults using FEV1/FVC < 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes Thorax 63 2008 1040 1045
26. P.L. Enright, and D.A. Kaminsky Strategies for screening for chronic obstructive pulmonary disease Respir Care 48 2003 1194 1201 [discussion 201-3]
27. J.E. Hansen, X.G. Sun, and K. Wasserman Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70% Chest 131 2007 349 355
28. E. Hnizdo, H.W. Glindmeyer, E.L. Petsonk, P. Enright, and A.S. Buist Case definitions for chronic obstructive pulmonary disease COPD 3 2006 95 100
29. A.C. Lau, M.S. Ip, C.K. Lai, K.L. Choo, K.S. Tang, and L.Y. Yam Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria Chest 133 2008 42 48
30. M.P. Swanney, G. Ruppel, P.L. Enright, O.F. Pedersen, R.O. Crapo, and M.R. Miller Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction Thorax 63 2008 1046 1051
31. W.M. Vollmer, T. Gislason, P. Burney, P.L. Enright, A. Gulsvik, and A. Kocabas Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Eur Respir J 34 2009 588 597
32. R. Pellegrino, V. Brusasco, G. Viegi, R.O. Crapo, F. Burgos, and R. Casaburi Definition of COPD: based on evidence or opinion? Eur Respir J 31 2008 681 682
33. C. Sorino, S. Battaglia, N. Scichilone, C. Pedone, R. Antonelli-Incalzi, and D. Sherrill Diagnosis of airway obstruction in the elderly: contribution of the SARA study Int J Chron Obstruct Pulmon Dis 7 2012 389 395
34. R.O. Crapo, R. Casaburi, A.L. Coates, P.L. Enright, J.L. Hankinson, and C.G. Irvin Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am J Respir Crit Care Med 161 2000 309 329
35. R. de Marco What evidence could validate the definition of COPD? Thorax 63 2008 756 757
36. P.O. Bridevaux, M.W. Gerbase, N.M. Probst-Hensch, C. Schindler, J.M. Gaspoz, and T. Rochat Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD Thorax 63 2008 768 774
37. G. Guder, S. Brenner, C.E. Angermann, G. Ertl, M. Held, and A.P. Sachs GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study Respir Res 13 2012 13
38. D. Ofir, P. Laveneziana, K.A. Webb, Y.M. Lam, and D.E. O'Donnell Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 622 629